Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.

By Hernández Hernández, Felipe | Albarrán González-Trevilla, Agustín. JACC. Cardiovascular interventions, 2014 . 7(3):244-54. , Formato Vancouver: De la Torre Hernández JM, Baz Alonso JA, Gómez Hospital JA, Alfonso Manterola F, García Camarero T, Gimeno de Carlos F et al; IVUS-TRONCO-ICP Spanish study. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014 Mar;7(3):244-54.

Place Hold on Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.

Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough?

By Molina Martín de Nicolás, Javier | Jurado Román, Alfonso | Rubio Alonso, Belén | García Tejada, Julio. JACC. Cardiovascular interventions, 2015 . 8(4):e55-7. , Formato Vancouver: Molina Martín de Nicolás J, Jurado Román A, Rubio Alonso B, García Tejada J. Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough? JACC Cardiovasc Interv. 2015 Apr 20;8(4):e55-7.

Place Hold on Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough?

Search for 'Provider:JACC. Cardiovascular interventions,'

Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.

Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough?